nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Progesterone—uterine cancer	0.0836	0.186	CbGbCtD
Bromocriptine—ABCB1—Progesterone—uterine cancer	0.0731	0.162	CbGbCtD
Bromocriptine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0661	0.147	CbGbCtD
Bromocriptine—ABCB1—Dactinomycin—uterine cancer	0.058	0.129	CbGbCtD
Bromocriptine—CYP3A4—Progesterone—uterine cancer	0.0438	0.0973	CbGbCtD
Bromocriptine—CYP1A2—Etoposide—uterine cancer	0.0374	0.0831	CbGbCtD
Bromocriptine—ABCB1—Etoposide—uterine cancer	0.0327	0.0727	CbGbCtD
Bromocriptine—ABCB1—Doxorubicin—uterine cancer	0.0223	0.0496	CbGbCtD
Bromocriptine—CYP3A4—Etoposide—uterine cancer	0.0196	0.0436	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—uterine cancer	0.0134	0.0297	CbGbCtD
Bromocriptine—HTR1B—artery—uterine cancer	0.00673	0.0568	CbGeAlD
Bromocriptine—HTR1D—artery—uterine cancer	0.00652	0.0549	CbGeAlD
Bromocriptine—HTR7—artery—uterine cancer	0.00519	0.0438	CbGeAlD
Bromocriptine—ADRA1D—epithelium—uterine cancer	0.00331	0.0279	CbGeAlD
Bromocriptine—HTR2A—artery—uterine cancer	0.00324	0.0273	CbGeAlD
Bromocriptine—ADRA1B—renal system—uterine cancer	0.00314	0.0264	CbGeAlD
Bromocriptine—DRD5—female reproductive system—uterine cancer	0.00306	0.0258	CbGeAlD
Bromocriptine—HTR2B—myometrium—uterine cancer	0.00293	0.0247	CbGeAlD
Bromocriptine—DRD5—female gonad—uterine cancer	0.00279	0.0235	CbGeAlD
Bromocriptine—ADRA1D—female reproductive system—uterine cancer	0.00246	0.0207	CbGeAlD
Bromocriptine—ADRA2C—myometrium—uterine cancer	0.00231	0.0194	CbGeAlD
Bromocriptine—HTR2B—uterine cervix—uterine cancer	0.00228	0.0192	CbGeAlD
Bromocriptine—HTR2B—smooth muscle tissue—uterine cancer	0.00222	0.0187	CbGeAlD
Bromocriptine—HTR2B—decidua—uterine cancer	0.00217	0.0183	CbGeAlD
Bromocriptine—HTR2B—endometrium—uterine cancer	0.00206	0.0174	CbGeAlD
Bromocriptine—HTR7—epithelium—uterine cancer	0.00197	0.0166	CbGeAlD
Bromocriptine—HTR1A—renal system—uterine cancer	0.00191	0.0161	CbGeAlD
Bromocriptine—HTR2B—uterus—uterine cancer	0.0019	0.016	CbGeAlD
Bromocriptine—ADRA1A—epithelium—uterine cancer	0.0019	0.016	CbGeAlD
Bromocriptine—HTR7—smooth muscle tissue—uterine cancer	0.0019	0.016	CbGeAlD
Bromocriptine—HTR1B—female reproductive system—uterine cancer	0.0019	0.016	CbGeAlD
Bromocriptine—ADRA2A—myometrium—uterine cancer	0.00184	0.0155	CbGeAlD
Bromocriptine—HTR1D—female reproductive system—uterine cancer	0.00184	0.0155	CbGeAlD
Bromocriptine—HTR7—renal system—uterine cancer	0.00183	0.0154	CbGeAlD
Bromocriptine—HTR2C—female reproductive system—uterine cancer	0.00182	0.0153	CbGeAlD
Bromocriptine—ADRA2C—uterine cervix—uterine cancer	0.00179	0.0151	CbGeAlD
Bromocriptine—ADRB1—female reproductive system—uterine cancer	0.00178	0.015	CbGeAlD
Bromocriptine—ADRA1A—renal system—uterine cancer	0.00176	0.0148	CbGeAlD
Bromocriptine—ADRA2C—decidua—uterine cancer	0.00171	0.0144	CbGeAlD
Bromocriptine—HTR2B—female reproductive system—uterine cancer	0.00171	0.0144	CbGeAlD
Bromocriptine—ADRA2C—renal system—uterine cancer	0.00168	0.0141	CbGeAlD
Bromocriptine—ADRA2C—endometrium—uterine cancer	0.00162	0.0137	CbGeAlD
Bromocriptine—ADRA2C—mammalian vulva—uterine cancer	0.00157	0.0132	CbGeAlD
Bromocriptine—HTR2B—vagina—uterine cancer	0.00154	0.013	CbGeAlD
Bromocriptine—ADRA2C—uterus—uterine cancer	0.0015	0.0126	CbGeAlD
Bromocriptine—HTR7—female reproductive system—uterine cancer	0.00146	0.0123	CbGeAlD
Bromocriptine—CYP1A2—renal system—uterine cancer	0.00146	0.0123	CbGeAlD
Bromocriptine—ADRA2A—uterine cervix—uterine cancer	0.00143	0.0121	CbGeAlD
Bromocriptine—ADRA2A—decidua—uterine cancer	0.00136	0.0115	CbGeAlD
Bromocriptine—ADRA2A—endometrium—uterine cancer	0.0013	0.0109	CbGeAlD
Bromocriptine—ADRA2A—mammalian vulva—uterine cancer	0.00125	0.0106	CbGeAlD
Bromocriptine—HTR2A—epithelium—uterine cancer	0.00123	0.0103	CbGeAlD
Bromocriptine—ADRA2C—female gonad—uterine cancer	0.00122	0.0103	CbGeAlD
Bromocriptine—ADRA2C—vagina—uterine cancer	0.00122	0.0102	CbGeAlD
Bromocriptine—ADRA2A—uterus—uterine cancer	0.00119	0.0101	CbGeAlD
Bromocriptine—HTR2A—smooth muscle tissue—uterine cancer	0.00118	0.00997	CbGeAlD
Bromocriptine—HTR2A—renal system—uterine cancer	0.00114	0.0096	CbGeAlD
Bromocriptine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00111	0.00256	CcSEcCtD
Bromocriptine—Fatigue—Progesterone—uterine cancer	0.0011	0.00256	CcSEcCtD
Bromocriptine—Dyskinesia—Epirubicin—uterine cancer	0.0011	0.00254	CcSEcCtD
Bromocriptine—Constipation—Progesterone—uterine cancer	0.0011	0.00254	CcSEcCtD
Bromocriptine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00252	CcSEcCtD
Bromocriptine—ADRA2A—female reproductive system—uterine cancer	0.00107	0.00904	CbGeAlD
Bromocriptine—Feeling abnormal—Progesterone—uterine cancer	0.00106	0.00245	CcSEcCtD
Bromocriptine—CYP3A4—renal system—uterine cancer	0.00105	0.00889	CbGeAlD
Bromocriptine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00243	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Progesterone—uterine cancer	0.00105	0.00243	CcSEcCtD
Bromocriptine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00242	CcSEcCtD
Bromocriptine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.0024	CcSEcCtD
Bromocriptine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00239	CcSEcCtD
Bromocriptine—Ventricular tachycardia—Epirubicin—uterine cancer	0.00103	0.00239	CcSEcCtD
Bromocriptine—ABCB1—myometrium—uterine cancer	0.00103	0.00864	CbGeAlD
Bromocriptine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00237	CcSEcCtD
Bromocriptine—Urticaria—Progesterone—uterine cancer	0.00102	0.00236	CcSEcCtD
Bromocriptine—Dyskinesia—Doxorubicin—uterine cancer	0.00101	0.00235	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Etoposide—uterine cancer	0.00101	0.00235	CcSEcCtD
Bromocriptine—Abdominal pain—Progesterone—uterine cancer	0.00101	0.00235	CcSEcCtD
Bromocriptine—Body temperature increased—Progesterone—uterine cancer	0.00101	0.00235	CcSEcCtD
Bromocriptine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00234	CcSEcCtD
Bromocriptine—Myocardial infarction—Etoposide—uterine cancer	0.00101	0.00234	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00232	CcSEcCtD
Bromocriptine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00232	CcSEcCtD
Bromocriptine—HTR2B—lymph node—uterine cancer	0.000999	0.00842	CbGeAlD
Bromocriptine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000993	0.0023	CcSEcCtD
Bromocriptine—ADRA2A—female gonad—uterine cancer	0.000976	0.00823	CbGeAlD
Bromocriptine—ADRA2A—vagina—uterine cancer	0.00097	0.00818	CbGeAlD
Bromocriptine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000957	0.00222	CcSEcCtD
Bromocriptine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000953	0.00221	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00095	0.0022	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Epirubicin—uterine cancer	0.000946	0.00219	CcSEcCtD
Bromocriptine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000923	0.00214	CcSEcCtD
Bromocriptine—Asthenia—Progesterone—uterine cancer	0.00092	0.00213	CcSEcCtD
Bromocriptine—Hypoaesthesia—Etoposide—uterine cancer	0.000918	0.00213	CcSEcCtD
Bromocriptine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000918	0.00213	CcSEcCtD
Bromocriptine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000918	0.00213	CcSEcCtD
Bromocriptine—HTR2A—female reproductive system—uterine cancer	0.000912	0.00769	CbGeAlD
Bromocriptine—Oedema—Dactinomycin—uterine cancer	0.000906	0.0021	CcSEcCtD
Bromocriptine—Infection—Dactinomycin—uterine cancer	0.0009	0.00209	CcSEcCtD
Bromocriptine—Diarrhoea—Progesterone—uterine cancer	0.000877	0.00203	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000876	0.00203	CcSEcCtD
Bromocriptine—Anorexia—Dactinomycin—uterine cancer	0.000863	0.002	CcSEcCtD
Bromocriptine—Eye disorder—Etoposide—uterine cancer	0.000862	0.002	CcSEcCtD
Bromocriptine—Diabetes mellitus—Epirubicin—uterine cancer	0.00086	0.00199	CcSEcCtD
Bromocriptine—Cardiac disorder—Etoposide—uterine cancer	0.000856	0.00198	CcSEcCtD
Bromocriptine—Dizziness—Progesterone—uterine cancer	0.000847	0.00196	CcSEcCtD
Bromocriptine—CYP3A4—female reproductive system—uterine cancer	0.000844	0.00712	CbGeAlD
Bromocriptine—Angiopathy—Etoposide—uterine cancer	0.000837	0.00194	CcSEcCtD
Bromocriptine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000833	0.00193	CcSEcCtD
Bromocriptine—Mediastinal disorder—Etoposide—uterine cancer	0.000832	0.00193	CcSEcCtD
Bromocriptine—HTR2A—vagina—uterine cancer	0.000825	0.00695	CbGeAlD
Bromocriptine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000824	0.00191	CcSEcCtD
Bromocriptine—Alopecia—Etoposide—uterine cancer	0.000815	0.00189	CcSEcCtD
Bromocriptine—Vomiting—Progesterone—uterine cancer	0.000815	0.00189	CcSEcCtD
Bromocriptine—Rash—Progesterone—uterine cancer	0.000808	0.00187	CcSEcCtD
Bromocriptine—Dermatitis—Progesterone—uterine cancer	0.000807	0.00187	CcSEcCtD
Bromocriptine—ABCB1—epithelium—uterine cancer	0.000805	0.00678	CbGeAlD
Bromocriptine—Headache—Progesterone—uterine cancer	0.000803	0.00186	CcSEcCtD
Bromocriptine—ABCB1—uterine cervix—uterine cancer	0.000798	0.00672	CbGeAlD
Bromocriptine—Diabetes mellitus—Doxorubicin—uterine cancer	0.000795	0.00184	CcSEcCtD
Bromocriptine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000795	0.00184	CcSEcCtD
Bromocriptine—Decreased appetite—Dactinomycin—uterine cancer	0.000787	0.00183	CcSEcCtD
Bromocriptine—Dysgeusia—Etoposide—uterine cancer	0.000787	0.00182	CcSEcCtD
Bromocriptine—ADRA2C—lymph node—uterine cancer	0.000787	0.00663	CbGeAlD
Bromocriptine—Fatigue—Dactinomycin—uterine cancer	0.000781	0.00181	CcSEcCtD
Bromocriptine—Muscle spasms—Etoposide—uterine cancer	0.000772	0.00179	CcSEcCtD
Bromocriptine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000768	0.00178	CcSEcCtD
Bromocriptine—Hypoglycaemia—Epirubicin—uterine cancer	0.000766	0.00178	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000763	0.00177	CcSEcCtD
Bromocriptine—Lethargy—Epirubicin—uterine cancer	0.000763	0.00177	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000763	0.00177	CcSEcCtD
Bromocriptine—Nausea—Progesterone—uterine cancer	0.000761	0.00176	CcSEcCtD
Bromocriptine—ABCB1—decidua—uterine cancer	0.00076	0.00641	CbGeAlD
Bromocriptine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000748	0.00173	CcSEcCtD
Bromocriptine—Diplopia—Epirubicin—uterine cancer	0.000748	0.00173	CcSEcCtD
Bromocriptine—Feeling abnormal—Dactinomycin—uterine cancer	0.000746	0.00173	CcSEcCtD
Bromocriptine—ABCB1—renal system—uterine cancer	0.000746	0.00629	CbGeAlD
Bromocriptine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000741	0.00172	CcSEcCtD
Bromocriptine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000738	0.00171	CcSEcCtD
Bromocriptine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000732	0.0017	CcSEcCtD
Bromocriptine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000732	0.0017	CcSEcCtD
Bromocriptine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00169	CcSEcCtD
Bromocriptine—Vertigo—Etoposide—uterine cancer	0.000722	0.00167	CcSEcCtD
Bromocriptine—ABCB1—endometrium—uterine cancer	0.000722	0.00608	CbGeAlD
Bromocriptine—Body temperature increased—Dactinomycin—uterine cancer	0.000716	0.00166	CcSEcCtD
Bromocriptine—Abdominal pain—Dactinomycin—uterine cancer	0.000716	0.00166	CcSEcCtD
Bromocriptine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000709	0.00164	CcSEcCtD
Bromocriptine—Loss of consciousness—Etoposide—uterine cancer	0.000706	0.00164	CcSEcCtD
Bromocriptine—Lethargy—Doxorubicin—uterine cancer	0.000706	0.00164	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000706	0.00164	CcSEcCtD
Bromocriptine—Ataxia—Epirubicin—uterine cancer	0.000703	0.00163	CcSEcCtD
Bromocriptine—ABCB1—mammalian vulva—uterine cancer	0.000698	0.00588	CbGeAlD
Bromocriptine—Convulsion—Etoposide—uterine cancer	0.000696	0.00161	CcSEcCtD
Bromocriptine—Hypertension—Etoposide—uterine cancer	0.000694	0.00161	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000692	0.0016	CcSEcCtD
Bromocriptine—Diplopia—Doxorubicin—uterine cancer	0.000692	0.0016	CcSEcCtD
Bromocriptine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00069	0.0016	CcSEcCtD
Bromocriptine—Abdominal pain upper—Epirubicin—uterine cancer	0.000683	0.00158	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000683	0.00158	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000679	0.00157	CcSEcCtD
Bromocriptine—Nasopharyngitis—Epirubicin—uterine cancer	0.000669	0.00155	CcSEcCtD
Bromocriptine—ABCB1—uterus—uterine cancer	0.000665	0.0056	CbGeAlD
Bromocriptine—Confusional state—Etoposide—uterine cancer	0.000661	0.00153	CcSEcCtD
Bromocriptine—Infection—Etoposide—uterine cancer	0.000651	0.00151	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—uterine cancer	0.000651	0.00151	CcSEcCtD
Bromocriptine—Asthenia—Dactinomycin—uterine cancer	0.00065	0.00151	CcSEcCtD
Bromocriptine—Dysphagia—Epirubicin—uterine cancer	0.000646	0.0015	CcSEcCtD
Bromocriptine—Influenza—Epirubicin—uterine cancer	0.000646	0.0015	CcSEcCtD
Bromocriptine—Tachycardia—Etoposide—uterine cancer	0.00064	0.00148	CcSEcCtD
Bromocriptine—Skin disorder—Etoposide—uterine cancer	0.000637	0.00148	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000632	0.00146	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000632	0.00146	CcSEcCtD
Bromocriptine—ADRA2A—lymph node—uterine cancer	0.000628	0.00529	CbGeAlD
Bromocriptine—Anorexia—Etoposide—uterine cancer	0.000625	0.00145	CcSEcCtD
Bromocriptine—Diarrhoea—Dactinomycin—uterine cancer	0.00062	0.00144	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000619	0.00143	CcSEcCtD
Bromocriptine—Hypotension—Etoposide—uterine cancer	0.000613	0.00142	CcSEcCtD
Bromocriptine—Dysphagia—Doxorubicin—uterine cancer	0.000598	0.00139	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—uterine cancer	0.000598	0.00139	CcSEcCtD
Bromocriptine—ABCB1—female reproductive system—uterine cancer	0.000598	0.00504	CbGeAlD
Bromocriptine—Pollakiuria—Epirubicin—uterine cancer	0.000597	0.00138	CcSEcCtD
Bromocriptine—Paraesthesia—Etoposide—uterine cancer	0.000589	0.00136	CcSEcCtD
Bromocriptine—Dyspnoea—Etoposide—uterine cancer	0.000584	0.00135	CcSEcCtD
Bromocriptine—Somnolence—Etoposide—uterine cancer	0.000583	0.00135	CcSEcCtD
Bromocriptine—Drowsiness—Epirubicin—uterine cancer	0.000576	0.00134	CcSEcCtD
Bromocriptine—Vomiting—Dactinomycin—uterine cancer	0.000576	0.00133	CcSEcCtD
Bromocriptine—Rash—Dactinomycin—uterine cancer	0.000571	0.00132	CcSEcCtD
Bromocriptine—Decreased appetite—Etoposide—uterine cancer	0.00057	0.00132	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000566	0.00131	CcSEcCtD
Bromocriptine—Fatigue—Etoposide—uterine cancer	0.000565	0.00131	CcSEcCtD
Bromocriptine—Constipation—Etoposide—uterine cancer	0.000561	0.0013	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—uterine cancer	0.000552	0.00128	CcSEcCtD
Bromocriptine—ABCB1—female gonad—uterine cancer	0.000544	0.00458	CbGeAlD
Bromocriptine—ABCB1—vagina—uterine cancer	0.000541	0.00456	CbGeAlD
Bromocriptine—Sinusitis—Epirubicin—uterine cancer	0.000541	0.00125	CcSEcCtD
Bromocriptine—Feeling abnormal—Etoposide—uterine cancer	0.00054	0.00125	CcSEcCtD
Bromocriptine—Nausea—Dactinomycin—uterine cancer	0.000538	0.00125	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Etoposide—uterine cancer	0.000536	0.00124	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—uterine cancer	0.000533	0.00124	CcSEcCtD
Bromocriptine—Bradycardia—Epirubicin—uterine cancer	0.000527	0.00122	CcSEcCtD
Bromocriptine—Urticaria—Etoposide—uterine cancer	0.000521	0.00121	CcSEcCtD
Bromocriptine—Rhinitis—Epirubicin—uterine cancer	0.000519	0.0012	CcSEcCtD
Bromocriptine—Abdominal pain—Etoposide—uterine cancer	0.000518	0.0012	CcSEcCtD
Bromocriptine—Body temperature increased—Etoposide—uterine cancer	0.000518	0.0012	CcSEcCtD
Bromocriptine—Hypoaesthesia—Epirubicin—uterine cancer	0.000515	0.00119	CcSEcCtD
Bromocriptine—Oedema peripheral—Epirubicin—uterine cancer	0.00051	0.00118	CcSEcCtD
Bromocriptine—Connective tissue disorder—Epirubicin—uterine cancer	0.000508	0.00118	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—uterine cancer	0.0005	0.00116	CcSEcCtD
Bromocriptine—Visual impairment—Epirubicin—uterine cancer	0.000498	0.00116	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—uterine cancer	0.000487	0.00113	CcSEcCtD
Bromocriptine—Eye disorder—Epirubicin—uterine cancer	0.000483	0.00112	CcSEcCtD
Bromocriptine—Tinnitus—Epirubicin—uterine cancer	0.000482	0.00112	CcSEcCtD
Bromocriptine—Cardiac disorder—Epirubicin—uterine cancer	0.00048	0.00111	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—uterine cancer	0.00048	0.00111	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000476	0.0011	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—uterine cancer	0.000471	0.00109	CcSEcCtD
Bromocriptine—Asthenia—Etoposide—uterine cancer	0.00047	0.00109	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—uterine cancer	0.00047	0.00109	CcSEcCtD
Bromocriptine—Angiopathy—Epirubicin—uterine cancer	0.000469	0.00109	CcSEcCtD
Bromocriptine—Mediastinal disorder—Epirubicin—uterine cancer	0.000466	0.00108	CcSEcCtD
Bromocriptine—Arrhythmia—Epirubicin—uterine cancer	0.000462	0.00107	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—uterine cancer	0.000461	0.00107	CcSEcCtD
Bromocriptine—Alopecia—Epirubicin—uterine cancer	0.000457	0.00106	CcSEcCtD
Bromocriptine—Mental disorder—Epirubicin—uterine cancer	0.000453	0.00105	CcSEcCtD
Bromocriptine—Diarrhoea—Etoposide—uterine cancer	0.000449	0.00104	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—uterine cancer	0.000447	0.00104	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—uterine cancer	0.000446	0.00103	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—uterine cancer	0.000444	0.00103	CcSEcCtD
Bromocriptine—Tension—Epirubicin—uterine cancer	0.000442	0.00102	CcSEcCtD
Bromocriptine—Dysgeusia—Epirubicin—uterine cancer	0.000441	0.00102	CcSEcCtD
Bromocriptine—Nervousness—Epirubicin—uterine cancer	0.000437	0.00101	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—uterine cancer	0.000434	0.00101	CcSEcCtD
Bromocriptine—Dizziness—Etoposide—uterine cancer	0.000434	0.001	CcSEcCtD
Bromocriptine—Muscle spasms—Epirubicin—uterine cancer	0.000433	0.001	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000431	0.001	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—uterine cancer	0.000428	0.000991	CcSEcCtD
Bromocriptine—Vision blurred—Epirubicin—uterine cancer	0.000424	0.000984	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—uterine cancer	0.000423	0.00098	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—uterine cancer	0.000419	0.000972	CcSEcCtD
Bromocriptine—Vomiting—Etoposide—uterine cancer	0.000417	0.000966	CcSEcCtD
Bromocriptine—Agitation—Epirubicin—uterine cancer	0.000414	0.000959	CcSEcCtD
Bromocriptine—Rash—Etoposide—uterine cancer	0.000413	0.000958	CcSEcCtD
Bromocriptine—Dermatitis—Etoposide—uterine cancer	0.000413	0.000957	CcSEcCtD
Bromocriptine—Headache—Etoposide—uterine cancer	0.000411	0.000952	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—uterine cancer	0.000409	0.000948	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—uterine cancer	0.000408	0.000946	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—uterine cancer	0.000405	0.000938	CcSEcCtD
Bromocriptine—Vertigo—Epirubicin—uterine cancer	0.000405	0.000938	CcSEcCtD
Bromocriptine—Syncope—Epirubicin—uterine cancer	0.000404	0.000936	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—uterine cancer	0.000401	0.000928	CcSEcCtD
Bromocriptine—Loss of consciousness—Epirubicin—uterine cancer	0.000396	0.000917	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—uterine cancer	0.000393	0.00091	CcSEcCtD
Bromocriptine—Convulsion—Epirubicin—uterine cancer	0.00039	0.000904	CcSEcCtD
Bromocriptine—Nausea—Etoposide—uterine cancer	0.000389	0.000903	CcSEcCtD
Bromocriptine—Hypertension—Epirubicin—uterine cancer	0.000389	0.000901	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—uterine cancer	0.000383	0.000887	CcSEcCtD
Bromocriptine—Anxiety—Epirubicin—uterine cancer	0.000382	0.000885	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000381	0.000882	CcSEcCtD
Bromocriptine—Dry mouth—Epirubicin—uterine cancer	0.000375	0.000869	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—uterine cancer	0.000374	0.000868	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—uterine cancer	0.000374	0.000866	CcSEcCtD
Bromocriptine—Confusional state—Epirubicin—uterine cancer	0.000371	0.000859	CcSEcCtD
Bromocriptine—Oedema—Epirubicin—uterine cancer	0.000367	0.000852	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—uterine cancer	0.000366	0.000849	CcSEcCtD
Bromocriptine—Infection—Epirubicin—uterine cancer	0.000365	0.000846	CcSEcCtD
Bromocriptine—Shock—Epirubicin—uterine cancer	0.000362	0.000838	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—uterine cancer	0.000361	0.000837	CcSEcCtD
Bromocriptine—Nervous system disorder—Epirubicin—uterine cancer	0.00036	0.000835	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—uterine cancer	0.00036	0.000834	CcSEcCtD
Bromocriptine—Tachycardia—Epirubicin—uterine cancer	0.000359	0.000831	CcSEcCtD
Bromocriptine—Skin disorder—Epirubicin—uterine cancer	0.000357	0.000827	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—uterine cancer	0.000353	0.000819	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000352	0.000816	CcSEcCtD
Bromocriptine—Anorexia—Epirubicin—uterine cancer	0.00035	0.000812	CcSEcCtD
Bromocriptine—ABCB1—lymph node—uterine cancer	0.00035	0.00295	CbGeAlD
Bromocriptine—Dry mouth—Doxorubicin—uterine cancer	0.000347	0.000804	CcSEcCtD
Bromocriptine—Hypotension—Epirubicin—uterine cancer	0.000343	0.000796	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—uterine cancer	0.000343	0.000795	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—uterine cancer	0.00034	0.000788	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—uterine cancer	0.000338	0.000783	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—uterine cancer	0.000335	0.000775	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—uterine cancer	0.000333	0.000773	CcSEcCtD
Bromocriptine—Insomnia—Epirubicin—uterine cancer	0.000332	0.00077	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—uterine cancer	0.000332	0.000769	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—uterine cancer	0.00033	0.000766	CcSEcCtD
Bromocriptine—Paraesthesia—Epirubicin—uterine cancer	0.00033	0.000765	CcSEcCtD
Bromocriptine—Dyspnoea—Epirubicin—uterine cancer	0.000328	0.000759	CcSEcCtD
Bromocriptine—Somnolence—Epirubicin—uterine cancer	0.000327	0.000757	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—uterine cancer	0.000324	0.000751	CcSEcCtD
Bromocriptine—Dyspepsia—Epirubicin—uterine cancer	0.000323	0.00075	CcSEcCtD
Bromocriptine—Decreased appetite—Epirubicin—uterine cancer	0.000319	0.00074	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—uterine cancer	0.000318	0.000736	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000317	0.000735	CcSEcCtD
Bromocriptine—Fatigue—Epirubicin—uterine cancer	0.000317	0.000734	CcSEcCtD
Bromocriptine—Constipation—Epirubicin—uterine cancer	0.000314	0.000728	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—uterine cancer	0.000308	0.000713	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—uterine cancer	0.000305	0.000708	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—uterine cancer	0.000303	0.000703	CcSEcCtD
Bromocriptine—Feeling abnormal—Epirubicin—uterine cancer	0.000303	0.000702	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—uterine cancer	0.000302	0.000701	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000301	0.000697	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—uterine cancer	0.000299	0.000694	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—uterine cancer	0.000296	0.000685	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000294	0.00068	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—uterine cancer	0.000293	0.000679	CcSEcCtD
Bromocriptine—Urticaria—Epirubicin—uterine cancer	0.000292	0.000677	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—uterine cancer	0.000291	0.000674	CcSEcCtD
Bromocriptine—Body temperature increased—Epirubicin—uterine cancer	0.000291	0.000673	CcSEcCtD
Bromocriptine—Abdominal pain—Epirubicin—uterine cancer	0.000291	0.000673	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—uterine cancer	0.00028	0.000649	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000278	0.000644	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—uterine cancer	0.00027	0.000626	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—uterine cancer	0.000269	0.000623	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—uterine cancer	0.000269	0.000623	CcSEcCtD
Bromocriptine—Asthenia—Epirubicin—uterine cancer	0.000264	0.000611	CcSEcCtD
Bromocriptine—Diarrhoea—Epirubicin—uterine cancer	0.000251	0.000583	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—uterine cancer	0.000244	0.000565	CcSEcCtD
Bromocriptine—Dizziness—Epirubicin—uterine cancer	0.000243	0.000563	CcSEcCtD
Bromocriptine—Vomiting—Epirubicin—uterine cancer	0.000234	0.000542	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—uterine cancer	0.000233	0.000539	CcSEcCtD
Bromocriptine—Rash—Epirubicin—uterine cancer	0.000232	0.000537	CcSEcCtD
Bromocriptine—Dermatitis—Epirubicin—uterine cancer	0.000231	0.000537	CcSEcCtD
Bromocriptine—Headache—Epirubicin—uterine cancer	0.00023	0.000534	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—uterine cancer	0.000225	0.000521	CcSEcCtD
Bromocriptine—Nausea—Epirubicin—uterine cancer	0.000218	0.000506	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—uterine cancer	0.000216	0.000501	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—uterine cancer	0.000214	0.000497	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—uterine cancer	0.000214	0.000496	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—uterine cancer	0.000213	0.000494	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—uterine cancer	0.000202	0.000468	CcSEcCtD
